{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:32:44Z","timestamp":1787509964747,"version":"build-2736575974"},"reference-count":75,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The endocannabinoid system (ECS) is a complex regulatory system, highly conserved among vertebrates. It has been widely described in nearly all human tissues. In the conjunctiva and cornea, the ECS is believed to play a pivotal role in the modulation of the local inflammatory state as well as in the regulation of tissue repair and fibrosis, neo-angiogenesis and pain perception. This review aims to summarize all the available data on ECS expression and its function in ocular surface structures to provide a specific insight concerning its modulation in dry eye disease, and to propose directions for future research.<\/jats:p>","DOI":"10.3390\/jcm9124036","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T22:30:52Z","timestamp":1607985052000},"page":"4036","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["CannabinEYEds: The Endocannabinoid System as a Regulator of the Ocular Surface Nociception, Inflammatory Response, Neovascularization and Wound Healing"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6479-1807","authenticated-orcid":false,"given":"Francesco","family":"Aiello","sequence":"first","affiliation":[{"name":"Ophthalmology Unit, Department of Experimental Medicine, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Gallo Afflitto","sequence":"additional","affiliation":[{"name":"Ophthalmology Unit, Department of Experimental Medicine, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Peng Olivia","family":"Li","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3725-8211","authenticated-orcid":false,"given":"Alessio","family":"Martucci","sequence":"additional","affiliation":[{"name":"Ophthalmology Unit, Department of Experimental Medicine, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Cesareo","sequence":"additional","affiliation":[{"name":"Ophthalmology Unit, Department of Experimental Medicine, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Nucci","sequence":"additional","affiliation":[{"name":"Ophthalmology Unit, Department of Experimental Medicine, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijo.IJO_646_17","article-title":"Anatomy of cornea and ocular surface","volume":"66","author":"Sridhar","year":"2018","journal-title":"Indian J. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Wong, H.L., Poon, S.H.L., Bu, Y., Lo, A.C.Y., Jhanji, V., Chan, Y.K., and Shih, K.C. (2020). A Systematic Review on Cornea Epithelial-Stromal Homeostasis. Ophthalmic Res.","DOI":"10.1159\/000509030"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: Beyond CB(1) and CB(2)","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1021\/ja01092a065","article-title":"A Total Synthesis of Dl-Delta-1-Tetrahydrocannabinol, the Active Constituent of Hashish","volume":"87","author":"Mechoulam","year":"1965","journal-title":"J. Am. Chem. Soc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1476-5381.2011.01444.x","article-title":"Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-gamma","volume":"163","author":"Du","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.pbb.2014.07.008","article-title":"Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models","volume":"124","author":"Grim","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.febslet.2005.12.079","article-title":"Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition","volume":"580","author":"Nakajima","year":"2006","journal-title":"FEBS Lett."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1124\/mol.63.2.429","article-title":"Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid receptor-independent pathway","volume":"63","author":"Sancho","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0165-5728(94)90152-X","article-title":"Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis","volume":"55","author":"Schwarz","year":"1994","journal-title":"J. Neuroimmunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0167-5273(98)00031-X","article-title":"Pharmacological evidence for anandamide amidase in human cardiac and vascular tissues","volume":"64","author":"Bilfinger","year":"1998","journal-title":"Int. J. Cardiol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1006\/phrs.2000.0702","article-title":"2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1","volume":"42","author":"Stefano","year":"2000","journal-title":"Pharmacol. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"19238","DOI":"10.1074\/jbc.271.32.19238","article-title":"Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes","volume":"271","author":"Stefano","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"NS20170144","DOI":"10.1042\/NS20170144","article-title":"Potential for endocannabinoid system modulation in ocular pain and inflammation: Filling the gaps in current pharmacological options | Neuronal Signaling | Portland Press","volume":"2","author":"Lafreniere","year":"2018","journal-title":"Neuronal Signal."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Almogi-Hazan, O., and Or, R. (2020). Cannabis, the Endocannabinoid System and Immunity-the Journey from the Bedside to the Bench and Back. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124448"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Meccariello, R. (2020). Endocannabinoid System in Health and Disease: Current Situation and Future Perspectives. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103549"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrn3811","article-title":"Early phytocannabinoid chemistry to endocannabinoids and beyond","volume":"15","author":"Mechoulam","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"ref_19","first-page":"294","article-title":"Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease","volume":"10","author":"Kendall","year":"2016","journal-title":"Front. Cell Neurosci."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Mackie, K. (2005). Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb. Exp. Pharmacol.","DOI":"10.1007\/3-540-26573-2_10"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0009-3084(00)00189-4","article-title":"2-Arachidonoylglycerol and the cannabinoid receptors","volume":"108","author":"Sugiura","year":"2000","journal-title":"Chem. Phys. Lipids"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0009-3084(00)00195-X","article-title":"Cannabinoid receptors and the regulation of immune response","volume":"108","author":"Berdyshev","year":"2000","journal-title":"Chem. Phys. Lipids"},{"key":"ref_23","first-page":"2442","article-title":"Localization of cannabinoid CB1 receptors in the human anterior eye and retina","volume":"40","author":"Straiker","year":"1999","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1167\/iovs.07-1319","article-title":"Cannabinoid receptors in conjunctival epithelium: Identification and functional properties","volume":"49","author":"Iribarne","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.3892\/mmr.2017.7246","article-title":"Immunolocalization of cannabinoid receptor type 1 and CB2 cannabinoid receptors, and transient receptor potential vanilloid channels in pterygium","volume":"16","author":"Assimakopoulou","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_26","first-page":"6927","article-title":"Cannabinoid Receptors and Corneal Epithelium Repair","volume":"50","author":"Suburo","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.exer.2019.03.011","article-title":"Cannabinoid CB2R receptors are upregulated with corneal injury and regulate the course of corneal wound healing","volume":"182","author":"Murataeva","year":"2019","journal-title":"Exp. Eye Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1167\/iovs.14-15675","article-title":"Cannabinoid-Induced Chemotaxis in Bovine Corneal Epithelial Cells","volume":"56","author":"Murataeva","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1182\/blood-2010-09-307355","article-title":"Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis","volume":"117","author":"Pisanti","year":"2011","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Thapa, D., Cairns, E.A., Szczesniak, A.M., Kulkarni, P.M., Straiker, A.J., Thakur, G.A., and Kelly, M.E.M. (2020). Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation. Molecules, 25.","DOI":"10.3390\/molecules25020417"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/can.2017.0041","article-title":"The Cannabinoids Delta(8)THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation","volume":"3","author":"Thapa","year":"2018","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0304-3959(02)00271-3","article-title":"Topical cannabinoid agonist, WIN55,212-2, reduces cornea-evoked trigeminal brainstem activity in the rat","volume":"99","author":"Bereiter","year":"2002","journal-title":"Pain"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-981-10-7757-9_6","article-title":"Transient Receptor Potential (TRP) Channels","volume":"87","author":"Samanta","year":"2018","journal-title":"Subcell. Biochem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.bjp.0705467","article-title":"Anandamide and vanilloid TRPV1 receptors","volume":"140","author":"Ross","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.cellsig.2012.10.015","article-title":"Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury","volume":"25","author":"Yang","year":"2013","journal-title":"Cell Signal."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1097\/ICO.0000000000000602","article-title":"Transient Receptor Potential Channels and Corneal Stromal Inflammation","volume":"34","author":"Okada","year":"2015","journal-title":"Cornea"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000365334","article-title":"Temperature-sensitive transient receptor potential channels in corneal tissue layers and cells","volume":"52","author":"Mergler","year":"2014","journal-title":"Ophthalmic Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.288.5464.306","article-title":"Impaired nociception and pain sensation in mice lacking the capsaicin receptor","volume":"288","author":"Caterina","year":"2000","journal-title":"Science"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1167\/iovs.10-5801","article-title":"TRPV1 activation is required for hypertonicity-stimulated inflammatory cytokine release in human corneal epithelial cells","volume":"52","author":"Pan","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/jcp.21141","article-title":"Transient receptor potential vanilloid 1 activation induces inflammatory cytokine release in corneal epithelium through MAPK signaling","volume":"213","author":"Zhang","year":"2007","journal-title":"J. Cell Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00441-018-2878-y","article-title":"Impaired healing of cornea incision injury in a TRPV1-deficient mouse","volume":"374","author":"Sumioka","year":"2018","journal-title":"Cell Tissue Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/j.ajpath.2011.02.043","article-title":"TRPV1 Involvement in Inflammatory Tissue Fibrosis in Mice","volume":"178","author":"Okada","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"706404","DOI":"10.1155\/2015\/706404","article-title":"Suppression of In Vivo Neovascularization by the Loss of TRPV1 in Mouse Cornea","volume":"2015","author":"Tomoyose","year":"2015","journal-title":"J. Ophthalmol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00109-006-0040-x","article-title":"CB1 and TRPV1 receptors mediate protective effects on colonic electrophysiological properties in mice","volume":"84","author":"Sibaev","year":"2006","journal-title":"J. Mol. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.neuroscience.2009.05.024","article-title":"Cannabinoid 1 receptor activation inhibits transient receptor potential vanilloid type 1 receptor-mediated cationic influx into rat cultured primary sensory neurons","volume":"162","author":"Mahmud","year":"2009","journal-title":"Neuroscience"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.exer.2010.06.022","article-title":"Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells","volume":"91","author":"Yang","year":"2010","journal-title":"Exp. Eye Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nm1025","article-title":"PPARs and the complex journey to obesity","volume":"10","author":"Evans","year":"2004","journal-title":"Nat. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm.3159","article-title":"PPARgamma signaling and metabolism: The good, the bad and the future","volume":"19","author":"Ahmadian","year":"2013","journal-title":"Nat. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1038\/sj.ijo.0802499","article-title":"Peroxisome proliferator-activated receptors and inflammation: From basic science to clinical applications","volume":"27","author":"Chinetti","year":"2003","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nri912","article-title":"Emerging roles of PPARs in inflammation and immunity","volume":"2","author":"Daynes","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"17078","DOI":"10.3390\/molecules191117078","article-title":"Endocannabinoids, related compounds and their metabolic routes","volume":"19","author":"Fezza","year":"2014","journal-title":"Molecules"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.3892\/mmr.2014.2041","article-title":"Decreased PPAR-gamma expression in the conjunctiva and increased expression of TNF-alpha and IL-1beta in the conjunctiva and tear fluid of dry eye mice","volume":"9","author":"Chen","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.exer.2004.10.009","article-title":"Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand","volume":"80","author":"Sarayba","year":"2005","journal-title":"Exp. Eye Res."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Nakano, Y., Uchiyama, M., Arima, T., Nagasaka, S., Igarashi, T., Shimizu, A., and Takahashi, H. (2018). PPARalpha Agonist Suppresses Inflammation after Corneal Alkali Burn by Suppressing Proinflammatory Cytokines, MCP-1, and Nuclear Translocation of NF-kappaB. Molecules, 24.","DOI":"10.3390\/molecules24010114"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/108076803322660495","article-title":"Peroxisome proliferator-activated receptor agonists inhibit interleukin-1beta-mediated nitric oxide production in cultured lacrimal gland acinar cells","volume":"19","author":"Beauregard","year":"2003","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"860","DOI":"10.18240\/ijo.2020.06.02","article-title":"PPARgamma: The dominant regulator among PPARs in dry eye lacrimal gland and diabetic lacrimal gland","volume":"13","author":"Mu","year":"2020","journal-title":"Int. J. Ophthalmol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Tobita, Y., Arima, T., Nakano, Y., Uchiyama, M., Shimizu, A., and Takahashi, H. (2020). Peroxisome Proliferator-Activated Receptor Beta\/Delta Agonist Suppresses Inflammation and Promotes Neovascularization. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155296"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1167\/iovs.08-2282","article-title":"Suppression of injury-induced conjunctiva scarring by peroxisome proliferator-activated receptor gamma gene transfer in mice","volume":"50","author":"Yamanaka","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"C75","DOI":"10.1152\/ajpcell.00332.2006","article-title":"Effect of overexpression of PPARgamma on the healing process of corneal alkali burn in mice","volume":"293","author":"Saika","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_60","first-page":"2135","article-title":"An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model","volume":"19","author":"Uchiyama","year":"2013","journal-title":"Mol. Vis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"17763","DOI":"10.1038\/s41598-017-18113-3","article-title":"Peroxisome proliferator-activated receptor alpha agonist suppresses neovascularization by reducing both vascular endothelial growth factor and angiopoietin-2 in corneal alkali burn","volume":"7","author":"Arima","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1054\/plef.2001.0356","article-title":"Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance","volume":"66","author":"Sugiura","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.tibs.2010.05.008","article-title":"Intracellular trafficking of anandamide: New concepts for signaling","volume":"35","author":"Maccarrone","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bbalip.2011.08.004","article-title":"Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: A comprehensive review from an analytical and biological perspective","volume":"1811","author":"Zoerner","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12944-017-0586-3","article-title":"Polyunsaturated fatty acids: Any role in rheumatoid arthritis?","volume":"16","author":"Navarini","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1038\/s41467-020-19176-z","article-title":"Blood pro-resolving mediators are linked with synovial pathology and are predictive of DMARD responsiveness in rheumatoid arthritis","volume":"11","author":"Gomez","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.bbrc.2005.03.095","article-title":"Finding of endocannabinoids in human eye tissues: Implications for glaucoma","volume":"330","author":"Chen","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00109-020-01907-w","article-title":"Signaling lipids as diagnostic biomarkers for ocular surface cicatrizing conjunctivitis","volume":"98","author":"Yang","year":"2020","journal-title":"J. Mol. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","article-title":"TFOS DEWS II Report Executive Summary","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1167\/iovs.18-24304","article-title":"TRPV1 and TRPM8 Channels and Nocifensive Behavior in a Rat Model for Dry Eye","volume":"59","author":"Bereiter","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1089\/jop.2016.0117","article-title":"Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications","volume":"33","author":"Roberti","year":"2017","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/jbcpp-2015-0065","article-title":"Seeing over the horizon\u2014Targeting the endocannabinoid system for the treatment of ocular disease","volume":"27","author":"Cairns","year":"2016","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0014-4835(77)90260-3","article-title":"Cannabinoid penetration and chronic effects in the eye","volume":"24","author":"Green","year":"1977","journal-title":"Exp. Eye Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/15569527.2017.1322098","article-title":"Corneal endothelial changes in long-term cannabinoid users","volume":"37","author":"Polat","year":"2018","journal-title":"Cutan. Ocul. Toxicol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/bph.12545","article-title":"Anti-inflammatory effects of cannabinoid CB(2) receptor activation in endotoxin-induced uveitis","volume":"171","author":"Toguri","year":"2014","journal-title":"Br. J. Pharmacol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/12\/4036\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:44:43Z","timestamp":1760179483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/12\/4036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":75,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["jcm9124036"],"URL":"https:\/\/doi.org\/10.3390\/jcm9124036","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,14]]}}}